Ph.D. Alfred P. Spada - 01 Feb 2023 Form 3 Insider Report for Histogen Inc.

Role
Executive Vice President and Chief Scientific Officer
Signature
/s/ Susan A. Knudson as attorney-in-fact for Alfred P. Spada, Ph.D.
Issuer symbol
N/A
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
3
Filing time
03 Feb 2023, 15:22:51 UTC
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HSTO Common Stock 979 01 Feb 2023 Direct
holding HSTO Common Stock 1,235 01 Feb 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by a family trust of which Dr. Spada is a trustee.

Remarks:

Executive Vice President and Chief Scientific Officer